HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Iron showdown: IV vs. pills for heart failure fatigue
Disease control TerminatedThis trial tests whether intravenous (IV) iron or oral iron pills work better for adults with congestive heart failure who also have low iron levels. Participants are randomly assigned to receive either a one-time IV infusion of ferric carboxymaltose (with a possible repeat dose)…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: Syed Hamza Mufarrih • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Heart-Kidney drug trial halted early – what happened?
Disease control TerminatedThis early-stage trial tested an experimental drug called AZD3427 in 10 people with heart failure and reduced kidney function. The goal was to see if the drug could improve blood flow to the kidneys, measured with a special PET scan. However, the study was terminated early, so we…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC